National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 88790-88791 [2024-25938]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
88790
Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Stacey Nicole Williams,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, stacey.williams@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Research Grants in Hemostasis,
Thrombosis, Coagulation, and Blood
Transfusion.
Date: December 4, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Courtney Elaine Watkins,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–3093, courtney.watkins2@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Collaborative R01—Clinical Studies of
Mental Illness.
Date: December 4, 2024.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Emily Megan Kilroy,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Bethesda, MD
20892, (301) 594–0813, kilroyem@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Pulmonary Diseases.
Date: December 4, 2024.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bradley Nuss, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC7814 Bethesda, MD 20892, 301–451–
8754, nussb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Topics in Nephrology and Urology,
Date: December 5, 2024,
Time: 9:30 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications,
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
VerDate Sep<11>2014
17:38 Nov 07, 2024
Jkt 265001
Meeting Format: Virtual Meeting.
Contact Person: Frederique Yiannikouris,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3313,
frederique.yiannikouris@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cell, Molecular Biology,
Instrumentation, and Assay Development.
Date: December 5, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Tatiana V. Cohen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–455–2364,
tatiana.cohen@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: HIV/AIDS Behavioral Panel.
Date: December 5, 2024.
Time: 10:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mark P. Rubert, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–806–
6596, rubertm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Biology.
Date: December 5, 2024.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jian Cao, MD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 827–5902,
caojn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Metabolism.
Date: December 5, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jonathan Michael
Peterson, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 867–5309,
jonathan.peterson@nih.gov.
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 4, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–25937 Filed 11–7–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Research Education
Program Advancing the Careers of a Diverse
Research Workforce (R25 Clinical Trial Not
Allowed).
Date: December 3, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F58,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Mario Cerritelli, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F58, Rockville, MD
20892, 240–669–5199, cerritem@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\08NON1.SGM
08NON1
Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices
Dated: November 4, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–25938 Filed 11–7–24; 8:45 am]
BILLING CODE 4140–01–P
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Notice of Approval of Exemption for
Indigenous-Knowledge Informed
Activities by Native Hawaiian
Organizations
Advisory Council on Historic
Preservation.
ACTION: Notice.
AGENCY:
The Advisory Council on
Historic Preservation (ACHP) has
approved an exemption that would
relieve Federal agencies from the
historic preservation review
requirements under Section 106 of the
National Historic Preservation Act
regarding the effects of various
undertakings in Hawaii that are
proposed or directed by a Native
Hawaiian Organization (NHO), or
substantially led, designed, or managed
by an NHO, informed by Indigenous
Knowledge of that NHO, and related to
traditional cultural practices of Native
Hawaiians.
SUMMARY:
The exemption went into effect
on October 18, 2024.
FOR FURTHER INFORMATION CONTACT:
William Dancing Feather, (202) 517–
0195, wdancingfeather@achp.gov.
SUPPLEMENTARY INFORMATION: Section
106 of the National Historic
Preservation Act, 54 U.S.C. 306108
(Section 106 and NHPA), requires
Federal agencies to consider the effects
of projects they carry out, license/
permit/approve, or assist (undertakings)
on historic properties, and provide the
Advisory Council on Historic
Preservation (ACHP) a reasonable
opportunity to comment with regard to
such undertakings. Historic properties
are those properties that are listed in the
National Register of Historic Places
(National Register) or eligible for such
listing.
The NHPA authorizes the ACHP to
promulgate regulations for exempting
undertakings from any or all of the
requirements of Section 106. 54 U.S.C.
304108(c). The section 106 regulations,
found at 36 CFR part 800, detail the
process for the approval of such
exemptions at 36 CFR 800.14(c).
After following that process, on
October 18, 2024, the ACHP
membership, by a vote of 17 in favor,
ddrumheller on DSK120RN23PROD with NOTICES1
DATES:
VerDate Sep<11>2014
17:38 Nov 07, 2024
Jkt 265001
none against, and three abstentions,
approved the exemption reproduced at
the end of this notice.
I. Background
The ACHP acknowledges that Native
knowledge and expertise are crucial to
a full understanding of historic
properties that must be recognized in
the Section 106 review process.
Accordingly, the ACHP published the
2021 Traditional Knowledge and the
Section 106 Process: Information for
Federal Agencies and Other Participants
document to keep Federal agencies
apprised of their duty to incorporate
traditional knowledge in Section 106
decisions. Most recently, in March 2024,
the ACHP adopted a Policy Statement
on Indigenous Knowledge and Historic
Preservation calling for the respectful
integration of Indigenous Knowledge at
all levels of the Section 106 review
process. In particular, Principle 3 of this
policy describes ‘‘Indigenous
Knowledge’’ for purposes of Section 106
to include, but is not limited to, the
‘‘experiences, insights, and knowledge
held by Indian Tribes and NHOs that
can assist Federal agencies in
identifying, evaluating, assessing, and
resolving adverse effects to historic
properties that may be of religious and
cultural significance to them.’’
Moreover, Principle 4 of the policy
explains that section 106 agreement
documents and program alternatives
that relate to historic properties of
religious and cultural significance to an
Indian Tribe or NHO should recognize
Indigenous Knowledge in informed
decision making.
II. Exemption Criteria
As mentioned, exemptions are a
program alternative under 36 CFR
800.14(c) which may be proposed by a
Federal agency or by the ACHP.
Exempted categories must meet the
following three criteria: (i) the actions
within the program or category would
otherwise qualify as ‘‘undertakings’’ as
defined in § 800.16; (ii) the potential
effects of the undertakings within the
program or category upon historic
properties are foreseeable and likely to
be minimal or not adverse; and (iii) the
exemption of the program or category is
consistent with the purposes of the
NHPA.
The actions covered by the exemption
are undertakings. The ACHP identified
that certain Federal agencies reviewing
undertakings involving NHOs,
specifically those utilizing Indigenous
Knowledge, were experiencing
challenges in meeting section 106
requirements despite clear compliance
with the broad goals and outlines of
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
88791
Federal historic preservation policy.
Examples of such projects have
included, in the past, Federal grant
activities to NHOs, such as grants for
agricultural restoration in He1eia and
maintenance activities at Ulupō Heiau
in Kailua, and select Federal land
management actions.
The exemption applies to certain
types of undertakings to be carried out,
licensed, permitted, or assisted by
Federal agencies that are (1) proposed,
directed, or authorized by an NHO, or
substantially led, designed, or managed
by an NHO, (2) informed by Indigenous
Knowledge of that NHO, (3) related to
traditional cultural practices of Native
Hawaiians, and (4) preceded by the
submission of an attestation statement
by the NHO to the relevant Federal
agency. The types of activities that are
included are landscaping practices;
agricultural practices; rehabilitation,
preservation, restoration, or
reconstruction of water features and
systems, including fishponds, historic
pathways, sacred and traditional sites,
traditional Native Hawaiian buildings
and structures, properties of religious
and cultural significance to NHOs;
installation of interpretative signage;
and transfer of Federal property or
interest in Federal property to an NHO.
The undertaking’s potential effects are
likely to be minimal or not adverse. In
considering the likely potential effects
of the undertakings informed by NHOs
on historic properties, the ACHP Chair
and staff met with many representatives
of NHOs, Federal agencies, the Hawai1i
State Historic Preservation Office, and
other preservation partners. In addition,
the ACHP conducted public engagement
and consultation as further described
below.
Based on this input and input from
ACHP members, the likely effects of the
exempted undertakings on historic
properties (including those not of
religious and cultural significance to
NHOs), would be minimal or not
adverse, as such effects are defined in
36 CFR 800.16(i) and 800.5 respectively.
The exemption includes several
safeguards to limit the covered
undertakings’ effects to those that are
minimal or not adverse, including: the
requirements that covered activities
include only those informed by
Indigenous Knowledge of the NHO and
related to the traditional cultural
practices of Native Hawaiians; a
requirement that the NHO attest to its
involvement in the undertaking and the
undertaking’s relationship to Native
Hawaiian cultural practice; a carefully
prescribed list of covered activities,
each tied to Indigenous Knowledge of
the NHO and traditional cultural
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 89, Number 217 (Friday, November 8, 2024)]
[Notices]
[Pages 88790-88791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25938]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Research Education Program
Advancing the Careers of a Diverse Research Workforce (R25 Clinical
Trial Not Allowed).
Date: December 3, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F58,
Rockville, MD 20892 (Video Assisted Meeting).
Contact Person: Mario Cerritelli, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F58,
Rockville, MD 20892, 240-669-5199, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
[[Page 88791]]
Dated: November 4, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-25938 Filed 11-7-24; 8:45 am]
BILLING CODE 4140-01-P
